Raphael Pharmaceutical RAPH
OTC RAPH
$1.51 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

Raphael Pharmaceutical (RAPH) Other Accumulated Expenses (2022 - 2025)

Updated

Raphael Pharmaceutical (RAPH) recorded Other Accumulated Expenses of $297,700 in Q4 2025.

Analysis

Raphael Pharmaceutical (RAPH) Other Accumulated Expenses (2022 - 2025) Analysis & Trends

  • Annual Other Accumulated Expenses has a three-year compound annual growth rate of 9.9% (FY2022 to FY2025).
  • Across earlier years, Other Accumulated Expenses came in at $224,000 in FY2022.
  • The Q4 2025 figure is the highest quarterly Other Accumulated Expenses since Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Raphael Pharmaceutical 30.47 Mn 30.42 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 297,700.00
Sep 30, 2023 438,000.00
Dec 31, 2022 224,000.00
API Access

Raphael Pharmaceutical Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RAPH&period=max&api_key=YOUR_API_KEY